References

  1. Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A. Global Cancer Statistics, 2012. CA Cancer J Clin. 2015; 65(2): 87-108. PubMed | Google Scholar

  2. Dhillon PK, Yeole BB, Dikshit R, Kurkure AP, Bray F. Trends in breast, ovarian and cervical cancer incidence in Mumbai, India over a 30-year period, 1976-2005: an age-period-cohort analysis. Br J Cancer. 2011; 105(5): 723-30. PubMed | Google Scholar

  3. Goff BA, Mandel L, Muntz HG, Melancon CH. Ovarian carcinoma diagnosis: results of a national ovarian cancer survey. Cancer. 2000; 89(10): 2068-75. PubMed | Google Scholar

  4. Moen MD, Cliby WA, Wilson TO. Stage III papillary serous cystadenocarcinoma of the ovary in a 15- year-old female. Gynecol Oncol. 1994; 53(2): 274-6. PubMed | Google Scholar

  5. Tamalika Kundu, Tuhin Ray, Souvik Dutta. Advanced stage bilateral ovarian serous cystadenocarcinoma in a teenage girl presenting with low back pain: a rare case report. International Journal of Science and Research (IJSR). 2015; 4(4): 3035-37. Google Scholar

  6. Nguyen L, Cardenas-Goicoechea SJ, Gordon P, Curtin C, Momeni M, Chuang C, Fishman D. Biomarkers for early detection of ovarian cancer. Women's Health. 2013; 9(2): 171-87. PubMed | Google Scholar

  7. Odukogbe AA, Adebamowo CA, Ola B, Olayemi O, Oladokun A, Adewole IF et al. Ovarian cancer in Ibadan: characteristics and management. J Obstet Gynecol. 2004; 24(3): 294-7. PubMed | Google Scholar

  8. Jelovac D, Armstrong DK. Recent progress in the diagnosis and treatment of ovarian cancer. CA Cancer J Clin. 2011 May-Jun; 61(3):183-203. PubMed | Google Scholar

  9. Vang R, Shih LM, Kurman RJ. Ovarian low-grade and high-grade serous carcinoma: pathogenesis, clinicopathologic and molecular biologic features, and diagnostic problems. Adv Anat Pathol. 2009; 16(5): 267-282. PubMed | Google Scholar

  10. Deligeoroglou E, Eleftheriades M, Shiadoes V, Botsis D, Hasiakos D, Kontoravdis A, Creatsas G. Ovarian masses during adolescence: clinical, ultrasonographic and pathologic findings, serum tumor markers and endocrinological profile. Gynecol Endocrinol. 2004;19(1):1-8. PubMed | Google Scholar